Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 30Breast 29CNS 6Genitourinary 5Gastrointestinal 4Other hematologic neoplasm 3Thoracic 1Other 1Gynecologic 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 648Ovarian Neoplasms 438Endometrial Neoplasms 289Breast Neoplasms 178Uterine Cervical Dysplasia 133Neoplasms 86Carcinoma, Ovarian Epithelial 80Papillomavirus Infections 68Prostatic Neoplasms 67Uterine Neoplasms 66Vulvar Neoplasms 64Colorectal Neoplasms 59Fallopian Tube Neoplasms 54Colonic Neoplasms 47Peritoneal Neoplasms 45Pancreatic Neoplasms 45Lung Neoplasms 45Urinary Bladder Neoplasms 39Vaginal Neoplasms 34Gynecologic Cancer 33Stomach Neoplasms 32Head and Neck Neoplasms 31Hereditary Breast and Ovarian Cancer Syndrome 27Rectal Neoplasms 26Pelvic Neoplasms 26Sarcoma 25Melanoma 25Esophageal Neoplasms 25Recurrence 24Ovarian Cysts 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cognitive Dysfunction × Gynecologic × Clear all
NCT06662435 2026-03-23

GYNCOG

Northwestern University

Phase NA Completed
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡